Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 2Phase 4 1Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Endocrine 1

Conditions

Lymphoma, Follicular 200Lymphoma 199Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Leukemia 89Hodgkin Disease 89Lymphoma, Mantle-Cell 80Lymphoma, B-Cell, Marginal Zone 66Burkitt Lymphoma 65Leukemia, Myeloid, Acute 55Multiple Myeloma 52Lymphoma, Large-Cell, Immunoblastic 48Recurrence 44Neoplasms 38Myelodysplastic Syndromes 38Lymphoma, T-Cell, Cutaneous 36Mycosis Fungoides 30Lymphoma, Large-Cell, Anaplastic 30Waldenstrom Macroglobulinemia 28Leukemia, Myeloid, Chronic-Phase 28Myeloproliferative Disorders 27Lymphoma, B-Cell 27Leukemia, Myeloid, Accelerated Phase 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26Sezary Syndrome 25Leukemia, Biphenotypic, Acute 25Blast Crisis 24Primary Myelofibrosis 22

Interventions

sacubitril and valsartan sodium hydrate drug combination 1Amlodipine, Valsartan Drug Combination 1Amlodipine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Hypertension × Lymphoid × Clear all
NCT06236061 2026-01-13

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Novartis

Phase 3 Completed
718 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

NCT00392262 2016-11-18

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Novartis

Phase 3 Completed
224 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡